Literature DB >> 24415964

A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition.

Hans-Peter Sinn1, Hans Kreipe2.   

Abstract

The WHO Classification of Tumors of the Breast, 4th edition, is an update to the 3rd edition that was published in 2003, and covers all neoplastic and preneoplastic lesions of the breast. Changes to the 4th edition include new aspects and changes to the terminology that reflect our present-day knowledge of these lesions. Definitions for histopathological diagnosis are complemented by a description of clinical features, epidemiology, macroscopy, genetics, and prognostic and predictive features. In this review of the WHO classification, we have focused on invasive carcinomas, precursor lesions, and some benign epithelial proliferations.

Entities:  

Keywords:  Breast Cancer; Diagnostic criteria; Pathology; WHO classification

Year:  2013        PMID: 24415964      PMCID: PMC3683948          DOI: 10.1159/000350774

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  29 in total

Review 1.  Breast core needle biopsy: issues and controversies.

Authors:  Michael Bilous
Journal:  Mod Pathol       Date:  2010-05       Impact factor: 7.842

2.  Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma.

Authors:  Bing Wei; Tian Ding; Yan Xing; Wei Wei; Zhen Tian; Feng Tang; Susan Abraham; Khazi Nayeemuddin; Kelly Hunt; Yun Wu
Journal:  Cancer       Date:  2010-10-01       Impact factor: 6.860

3.  Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas.

Authors:  Cheryl B Hill; I-Tien Yeh
Journal:  Am J Clin Pathol       Date:  2005-01       Impact factor: 2.493

4.  Apocrine mammary carcinoma. A clinicopathologic study of 72 cases.

Authors:  A D Abati; M Kimmel; P P Rosen
Journal:  Am J Clin Pathol       Date:  1990-10       Impact factor: 2.493

5.  Concordance in histological and biological parameters between first and second primary breast cancers.

Authors:  Dezheng Huo; Stephanie Melkonian; Paul J Rathouz; Andrey Khramtsov; Olufunmilayo I Olopade
Journal:  Cancer       Date:  2010-10-13       Impact factor: 6.860

6.  Pure and mixed mucinous carcinomas of the breast: a clinicopathologic analysis of 61 cases with long-term follow-up.

Authors:  S Toikkanen; H Kujari
Journal:  Hum Pathol       Date:  1989-08       Impact factor: 3.466

7.  Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.

Authors:  Laura C Collins; Victor P Carlo; Harry Hwang; Todd S Barry; Allen M Gown; Stuart J Schnitt
Journal:  Am J Surg Pathol       Date:  2006-08       Impact factor: 6.394

8.  Neuroendocrine differentiation and prognosis in breast adenocarcinoma.

Authors:  A Miremadi; S E Pinder; A H S Lee; J A Bell; E C Paish; P Wencyk; C W Elston; R I Nicholson; R W Blamey; J F Robertson; I O Ellis
Journal:  Histopathology       Date:  2002-03       Impact factor: 5.087

9.  Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.

Authors:  Magali Lacroix-Triki; Paula H Suarez; Alan MacKay; Maryou B Lambros; Rachael Natrajan; Kay Savage; Felipe C Geyer; Britta Weigelt; Alan Ashworth; Jorge S Reis-Filho
Journal:  J Pathol       Date:  2010-11       Impact factor: 7.996

10.  Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.

Authors:  Daniel Wetterskog; Maria Angeles Lopez-Garcia; Maryou B Lambros; Roger A'Hern; Felipe C Geyer; Fernanda Milanezi; Maria C Cabral; Rachael Natrajan; Arnaud Gauthier; Kai-Keen Shiu; Nicholas Orr; Sami Shousha; Zoran Gatalica; Alan Mackay; Jose Palacios; Jorge S Reis-Filho; Britta Weigelt
Journal:  J Pathol       Date:  2011-10-20       Impact factor: 7.996

View more
  86 in total

1.  Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.

Authors:  Otto Metzger-Filho; Arlindo R Ferreira; Rinath Jeselsohn; William T Barry; Deborah A Dillon; Jane E Brock; Ines Vaz-Luis; Melissa E Hughes; Eric P Winer; Nancy U Lin
Journal:  Oncologist       Date:  2018-12-05

Review 2.  Molecular Classification and Future Therapeutic Challenges of Triple-negative Breast Cancer.

Authors:  Nikolaos Garmpis; Christos Damaskos; Anna Garmpi; Konstantinos Nikolettos; Dimitrios Dimitroulis; Evangelos Diamantis; Paraskevi Farmaki; Alexandros Patsouras; Errika Voutyritsa; Athanasios Syllaios; Constantinos G Zografos; Efstathios A Antoniou; Nikos Nikolettos; Alkiviadis Kostakis; Konstantinos Kontzoglou; Dimitrios Schizas; Afroditi Nonni
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

3.  Upgrade Rate of Pure Flat Epithelial Atypia Diagnosed at Core Needle Biopsy: A Systematic Review and Meta-Analysis.

Authors:  Rifat A Wahab; Su-Ju Lee; Margaret E Mulligan; Bin Zhang; Mary C Mahoney
Journal:  Radiol Imaging Cancer       Date:  2021-01-22

4.  Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer.

Authors:  Reva K Basho; Clinton Yam; Michael Gilcrease; Rashmi K Murthy; Thorunn Helgason; Daniel D Karp; Funda Meric-Bernstam; Kenneth R Hess; Vicente Valero; Constance Albarracin; Jennifer K Litton; Mariana Chavez-MacGregor; David Hong; Razelle Kurzrock; Gabriel N Hortobagyi; Filip Janku; Stacy L Moulder
Journal:  Oncologist       Date:  2018-08-23

Review 5.  Therapeutic Implications of the Molecular and Immune Landscape of Triple-Negative Breast Cancer.

Authors:  Ana C Gregório; Manuela Lacerda; Paulo Figueiredo; Sérgio Simões; Sérgio Dias; João Nuno Moreira
Journal:  Pathol Oncol Res       Date:  2017-09-14       Impact factor: 3.201

6.  Preclinical ex vivo evaluation of the diagnostic performance of a new device for in situ label-free fluorescence spectral analysis of breast masses.

Authors:  Marie-Christine Mathieu; Alexis Toullec; Charlotte Benoit; Richard Berry; Pierre Validire; Pauline Beaumel; Yves Vincent; Pierre Maroun; Philippe Vielh; Lama Alchab; René Farcy; Hélène Moniz-Koum; Marie-Pierre Fontaine-Aupart; Suzette Delaloge; Corinne Balleyguier
Journal:  Eur Radiol       Date:  2018-01-05       Impact factor: 5.315

7.  Whole-lesion histogram and texture analyses of breast lesions on inline quantitative DCE mapping with CAIPIRINHA-Dixon-TWIST-VIBE.

Authors:  Kun Sun; Hong Zhu; Weimin Chai; Ying Zhan; Dominik Nickel; Robert Grimm; Caixia Fu; Fuhua Yan
Journal:  Eur Radiol       Date:  2019-08-01       Impact factor: 5.315

8.  Diagnostic Pitfalls in Papillary Lesions of the Breast: Experience from a Single Tertiary Care Center.

Authors:  Sridevi Hanaganahalli Basavaiah; Jessica Minal; Saraswathy Sreeram; Pooja Kundapur Suresh; Hema Kini; Deepa Adiga; Kausalya Kumari Sahu; Radha R Pai
Journal:  J Clin Diagn Res       Date:  2016-08-01

Review 9.  Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.

Authors:  Vida Pourteimoor; Samira Mohammadi-Yeganeh; Mahdi Paryan
Journal:  Tumour Biol       Date:  2016-09-20

Review 10.  Is the false-positive rate in mammography in North America too high?

Authors:  Michelle T Le; Carmel E Mothersill; Colin B Seymour; Fiona E McNeill
Journal:  Br J Radiol       Date:  2016-06-08       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.